Trial intelligence / Profile preview

MiMedx AmnioFix in Living Donor Liver Transplant

NCT07102550Phase 2Recruiting

Start
Oct 2024
Primary completion
Jul 2027
Modality
Implantable Devices, Implantable Hydrogels, Tissue Cells
Countries
1
01

Overview

A Phase 2 trial of AmnioFix in liver transplant. Started Oct 2024; status: recruiting.

02

Drugs

AmnioFix
03

Conditions

liver transplant

Beyond the preview

Go deeper on NCT07102550.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT07102550.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call